📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation. (2022)

First Author: Richardson TG

Attributed to: Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3001547

PubMed Identifier: 35213538

Publication URI: http://europepmc.org/abstract/MED/35213538

Type: Journal Article/Review

Volume: 20

Parent Publication: PLoS biology

Issue: 2

ISSN: 1544-9173